These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7139849)

  • 1. Therapy of liver tumors metastatic from colorectal cancer with whole-liver radiation combined with 5-FU, adriamycin, and methotrexate.
    Volberding PA; Friedman MA; Resser KJ; Phillips TL
    Cancer Chemother Pharmacol; 1982; 9(1):17-21. PubMed ID: 7139849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of hepatocellular cancer with combined intrahepatic arterial chemotherapy and whole liver irradiation.
    Friedman MA; Volberding PA; Cassidy MJ; Resser KJ; Wasserman TH; Phillips TL
    Ann Acad Med Singap; 1980 Apr; 9(2):260-3. PubMed ID: 6252817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II evaluation of sequential hepatic artery infusion of 5-fluorouracil and hepatic irradiation in metastatic colorectal carcinoma.
    Miller RL; Bukowski RM; Andresen S; Gahbauer R
    J Surg Oncol; 1988 Jan; 37(1):1-4. PubMed ID: 3336213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled phase III clinical study of 4-epi-doxorubicin + 5-fluorouracil versus 5-fluorouracil alone in metastatic gastric and rectosigmoid cancer.
    Kolarić K; Potrebica V; Stanovnik M
    Oncology; 1986; 43(2):73-7. PubMed ID: 3513075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential therapy with methotrexate and 5-fluorouracil in the treatment of advanced colorectal carcinoma.
    Leone BA; Romero A; Rabinovich MG; Perez JE; Macchiavelli M; Strauss E
    J Clin Oncol; 1986 Jan; 4(1):23-7. PubMed ID: 3941331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double biochemical modulation of 5-fluorouracil by methotrexate and levo-folinic acid in the treatment of advanced digestive tract malignancies.
    Comella P; Palmieri G; Lorusso V; Catalano G; Nicollela D; Ianniello GP; Casaretti R; Montella M; Frasci G; Perna M; Comella G
    Eur J Cancer; 1996 Sep; 32A(10):1719-26. PubMed ID: 8983280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy for advanced breast cancer: response and effect on survival.
    Canellos GP; DeVita VT; Gold GL; Chabner BA; Schein PS; Young RC
    Ann Intern Med; 1976 Apr; 84(4):389-92. PubMed ID: 1259283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.
    Petrelli N; Herrera L; Rustum Y; Burke P; Creaven P; Stulc J; Emrich LJ; Mittelman A
    J Clin Oncol; 1987 Oct; 5(10):1559-65. PubMed ID: 2443619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adriamycin in combination for the treatment of breast cancer: a Southwest Oncology Group study.
    Tranum B; Hoogstraten B; Kennedy A; Vaughn CB; Samal B; Thigpen T; Rivkin S; Smith F; Palmer RL; Costanzi J; Tucker WG; Wilson H; Maloney TR
    Cancer; 1978 Jun; 41(6):2078-83. PubMed ID: 657081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 5-fluorouracil with 5-fluorouracil, cyclophosphamide, and methotrexate in metastatic colorectal carcinoma.
    Richards F; Pajak TL; Cooper MR; Spurr CL
    Cancer; 1975 Nov; 36(5):1589-92. PubMed ID: 1192350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.
    Polyzos A; Tsavaris N; Giannopoulos A; Bacoyiannis C; Papadimas V; Kalahanis N; Karatzas G; Kosmas C; Sakelaropoulos N; Archimandritis A; Papachristodoulou A; Kosmidis P
    Cancer Chemother Pharmacol; 1996; 38(3):292-7. PubMed ID: 8646806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II evaluation of recombinant alpha-2a-interferon and continuous infusion fluorouracil in previously untreated metastatic colorectal adenocarcinoma.
    Pazdur R; Ajani JA; Patt YZ; Gomez J; Bready B; Levin B
    Cancer; 1993 Feb; 71(4):1214-8. PubMed ID: 8435795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver.
    O'Connell MJ; Nagorney DM; Bernath AM; Schroeder G; Fitzgibbons RJ; Mailliard JA; Burch P; Bolton JS; Colon-Otero G; Krook JE
    J Clin Oncol; 1998 Jul; 16(7):2528-33. PubMed ID: 9667274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy.
    Lim L; Gibbs P; Yip D; Shapiro JD; Dowling R; Smith D; Little A; Bailey W; Liechtenstein M
    BMC Cancer; 2005 Oct; 5():132. PubMed ID: 16225697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined modality therapy of hepatic metastasis. Northern California Oncology Group Pilot Study.
    Friedman M; Cassidy M; Levine M; Phillips T; Spivack S; Resser KJ
    Cancer; 1979 Sep; 44(3):906-13. PubMed ID: 113078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trial.
    Leichman CG; Jacobson JR; Modiano M; Daniels JR; Zalupski MM; Doroshow JH; Fletcher WS; Macdonald JS
    Cancer; 1999 Sep; 86(5):775-81. PubMed ID: 10463975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.
    Witte RS; Cnaan A; Mansour EG; Barylak E; Harris JE; Schutt AJ
    Cancer; 2001 Mar; 91(5):1020-8. PubMed ID: 11251955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer.
    Lamar RE; Greco FA; Johnson DH; Murphy PB; Hainsworth JD
    Cancer; 1994 Apr; 73(7):1842-8. PubMed ID: 8137208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of sequential methotrexate and fluorouracil in advanced colorectal cancer.
    Panasci L; Ford J; Margolese R
    Cancer Chemother Pharmacol; 1985; 15(2):164-6. PubMed ID: 4017165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of sequential low-dose methotrexate and fluorouracil in advanced colorectal carcinoma: attempt at correlation with tissue and blood levels of phosphoribosylpyrophosphate.
    Kemeny NE; Ahmed T; Michaelson RA; Harper HD; Yip LC
    J Clin Oncol; 1984 Apr; 2(4):311-5. PubMed ID: 6200577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.